Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Protein Electrophoresis Immunotyping Serum Test

The Protein Electrophoresis Immunotyping Serum Test analyzes protein levels in your blood serum. It helps identify and monitor conditions, especially those related to cancer and immune system disorders. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
2 mL (1.5 mL minimum) serum collected in a Serum Separator Tube (SST). Grossly hemolysed samples are not accepted. Ship refrigerated or frozen.
Results
Results are typically available the next working day after sample collection, provided the sample is received by 9 am. Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test.
Test priceKSh 20,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Protein Electrophoresis Immunotyping Serum Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected cancer, particularly multiple myeloma or related disorders
  • ✓Evaluation of unexplained fatigue or weight loss
  • ✓Monitoring response to cancer treatment
  • ✓Investigation of immune system disorders
  • ✓Assessment of chronic inflammation
  • ✓Evaluation of kidney disease
02

In plain language

What this test helps you understand

This test helps in the diagnosis and monitoring of conditions affecting protein levels in the blood, such as certain cancers (like multiple myeloma) and immune system disorders. It can provide valuable information for guiding treatment decisions.
The Protein Electrophoresis Immunotyping Serum Test is a diagnostic procedure used to assess protein levels in the serum (the liquid part of your blood). This test is valuable in identifying and monitoring various health conditions, particularly those involving cancer and the immune system. By analyzing the different proteins present in your blood serum, healthcare providers can gain important insights into your health status and guide treatment decisions.

This test measures total protein levels, different protein fractions using densitometry, and identifies specific types of proteins through immunotyping. It is often recommended for individuals experiencing symptoms suggestive of cancer or immune disorders, or those with a family history of such conditions. Early detection and monitoring of treatment effectiveness are key benefits of this test.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test.
Sample2 mL (1.5 mL minimum) serum collected in a Serum Separator Tube (SST). Grossly hemolysed samples are not accepted. Ship refrigerated or frozen.
MethodologyCapillary Electrophoresis and Agarose Gel Immunofixation Electrophoresis.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test measures protein levels and patterns in the serum. It may not detect all types of cancer or immune disorders. Results should be interpreted in conjunction with other clinical findings and tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test measures the total amount of protein in your serum and breaks it down into different types (fractions) to identify specific proteins, particularly immunoglobulins.
No special preparation, such as fasting, is required for this test.
Results are typically available the next working day after the sample is collected and received by the laboratory.
Grossly hemolysed samples cannot be processed for this test and will need to be recollected.
This test is not typically used as a general cancer screening tool but is used to help diagnose and monitor specific types of cancer and related conditions.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp